Shares of Rite Aid Co. (NYSE:RAD) have earned a consensus recommendation of “Hold” from the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, six have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $2.75.
A number of research analysts recently weighed in on the company. Zacks Investment Research raised Rite Aid from a “sell” rating to a “hold” rating in a report on Monday. Vetr raised Rite Aid from a “buy” rating to a “strong-buy” rating and set a $2.54 price objective on the stock in a report on Thursday, January 25th. Evercore ISI assumed coverage on Rite Aid in a report on Thursday, January 4th. They set an “underperform” rating and a $1.50 price objective on the stock. Deutsche Bank assumed coverage on Rite Aid in a report on Monday, December 4th. They set a “hold” rating and a $2.25 price objective on the stock. Finally, Royal Bank of Canada set a $2.00 price objective on Rite Aid and gave the stock a “hold” rating in a report on Wednesday, October 25th.
Shares of Rite Aid (RAD) traded up $0.02 during mid-day trading on Friday, reaching $2.09. The company had a trading volume of 12,032,603 shares, compared to its average volume of 26,433,137. Rite Aid has a 52-week low of $1.38 and a 52-week high of $6.15. The firm has a market capitalization of $2,220.00, a price-to-earnings ratio of 18.91 and a beta of 1.76. The company has a debt-to-equity ratio of 3.66, a current ratio of 0.86 and a quick ratio of 0.59.
COPYRIGHT VIOLATION NOTICE: “Rite Aid Co. (RAD) Receives $2.75 Average Target Price from Analysts” was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.com-unik.info/2018/02/07/rite-aid-co-rad-receives-2-75-average-target-price-from-analysts.html.
Rite Aid Company Profile
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.